AGPU ▲ +6.1% - Axe Compute Inc. $AGPU - Axe Compute Sells Helomics AI Cancer Diagnostics Lab Business to DataMEDS AI, Completing Transition to Neocloud GPU-as-a-Service platform Axe Compute shares rose 6.1% today after the company completed its sale of Helomics, its AI cancer diagnostics lab business, to DataMEDS AI. The transaction marks the final step in Axe Compute's strategic pivot away from diagnostics toward its Neocloud GPU-as-a-Service platform, streamlining the company's focus on cloud computing infrastructure. 15-SEP-2026 08:30 AM ET